We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




PET Core Laboratory Provides Essential Element for Accurate Research

By HospiMedica International staff writers
Posted on 03 Aug 2009
A positron emission tomography (PET) core laboratory is qualifying sites to participate in multicenter research trials by reviewing the quantitative data of PET scans and qualitatively reviewing clinical PET images from each site. More...


American College of Radiology (ACR; Reston, VA, USA) Image Metrix, an organization involved in imaging trial design, techniques, data extraction, management, and analysis, works closely with the American College of Radiology Imaging Network (ACRIN) to conduct PET trials.

According to an article published online in the Journal of Nuclear Medicine (JNM), on June 12, 2009, ACRIN has developed a qualification procedure for PET scanners at participating institutions designed to check the basic system calibrations and to verify that the clinical image quality is adequate for semiquantitative analysis of PET data.

"Information obtained from PET imaging has increasingly demonstrated its promising role as a noninvasive biomarker for assessing disease status,” stated lead author, Joshua Scheuermann, MS, clinical physicist at the University of Pennsylvania. "The goal of the PET qualification program is to ensure we are obtaining reliable quantitative and qualitative data across all of the centers participating in PET clinical research.”

Of 101 detailed scanner applications, 12% failed because of incorrect standardized uptake value (SUV) or normalization calibrations. Minimizing errors in SUV measurement is critical to achieving accurate quantification in clinical trials. ACRIN's PET core laboratory shows that many sites are unable to maintain accurate SUV calibrations without additional training or supervision.

"The emerging role of PET imaging endpoints as in vivo biomarkers requires imaging studies to produce reliable quantitative, semiquantitative and qualitative results that can be used to assess disease status. Ensuring such consistency in multicenter clinical trials that involve imaging is problematic. The problem stems from the fact that the data acquisition and reconstruction are performed in many different settings and often with different types of instrumentation. As described in our most recent peer-reviewed publication, ACRIN has managed to develop a robust system to streamline data collection, data management and processing. Such system is paving the way for a better integration of molecular imaging in drug discovery processes,” stated deputy co-chair and medical director, PET Core Laboratory, ACRIN, Barry A. Siegel, M.D.

"The results from this highlight the importance of a central review of a site's data and images before data from a PET scanner can be used,” stated ACR Image Metrix general manager, Michael Morales. "The PET core laboratory is a key component of our research center providing accurate, reliable research results.”

ACR Image Metrix, located in the American College of Radiology Clinical Research Center (Philadelphia, PA, USA), applies imaging techniques as a predictive and prognostic biomarker improving the efficiency for drug and medical device development programs. The team of physicians and scientists at ACR Image Metrix, work with pharmaceutical, biotech, and medical device companies to increase the efficiency of drug and medical device development programs by integrating the appropriate imaging modalities.

Related Links:
American College of Radiology
American College of Radiology Imaging Network


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical Examination & Procedure Light
Vega 80
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.